These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19777282)

  • 1. Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment.
    Wali VB; Bachawal SV; Sylvester PW
    Lipids; 2009 Oct; 44(10):925-34. PubMed ID: 19777282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
    Wali VB; Sylvester PW
    Lipids; 2007 Dec; 42(12):1113-23. PubMed ID: 17701065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
    Wali VB; Bachawal SV; Sylvester PW
    Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
    Shirode AB; Sylvester PW
    Biomed Pharmacother; 2010 May; 64(5):327-32. PubMed ID: 19954924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of combined treatment with gamma-tocotrienol and statin on human malignant mesothelioma cells.
    Tuerdi G; Ichinomiya S; Sato H; Siddig S; Suwa E; Iwata H; Yano T; Ueno K
    Cancer Lett; 2013 Oct; 339(1):116-27. PubMed ID: 23879968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
    Bachawal SV; Wali VB; Sylvester PW
    BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor γ down-regulation mediates the inhibitory effect of d-δ-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes.
    Torabi S; Yeganehjoo H; Shen CL; Mo H
    Nutr Res; 2016 Dec; 36(12):1345-1352. PubMed ID: 27884413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells.
    Wali VB; Bachawal SV; Sylvester PW
    Apoptosis; 2009 Nov; 14(11):1366-77. PubMed ID: 19771520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Parker RA; Pearce BC; Clark RW; Gordon DA; Wright JJ
    J Biol Chem; 1993 May; 268(15):11230-8. PubMed ID: 8388388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-tocotrienol reverses multidrug resistance of breast cancer cells with a mechanism distinct from that of atorvastatin.
    Ding Y; Peng Y; Deng L; Fan J; Huang B
    J Steroid Biochem Mol Biol; 2017 Mar; 167():67-77. PubMed ID: 27864002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
    Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
    Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
    Tiwari RV; Parajuli P; Sylvester PW
    Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation and apoptosis induction by lovastatin and γ-tocotrienol in HL-60 cells via Ras/ERK/NF-κB and Ras/Akt/NF-κB signaling dependent down-regulation of glyoxalase 1 and HMG-CoA reductase.
    Chen CC; Liu TY; Huang SP; Ho CT; Huang TC
    Cell Signal; 2015 Nov; 27(11):2182-90. PubMed ID: 26208883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
    Mo H; Elson CE
    Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
    Akl MR; Ayoub NM; Sylvester PW
    Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ-Tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA reductase inhibitor.
    Deng L; Ding Y; Peng Y; Wu Y; Fan J; Li W; Yang R; Yang M; Fu Q
    Bone; 2014 Oct; 67():200-7. PubMed ID: 25019595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Impact of d-δ-Tocotrienol and Geranylgeraniol on the Growth and HMG CoA Reductase of Human DU145 Prostate Carcinoma Cells.
    Yeganehjoo H; DeBose-Boyd R; McFarlin BK; Mo H
    Nutr Cancer; 2017; 69(4):682-691. PubMed ID: 28362175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells.
    Ayoub NM; Bachawal SV; Sylvester PW
    Cell Prolif; 2011 Dec; 44(6):516-26. PubMed ID: 21973114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells.
    Yang Z; Xiao H; Jin H; Koo PT; Tsang DJ; Yang CS
    Int J Cancer; 2010 Feb; 126(4):852-63. PubMed ID: 19626588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.